The CORVOS doctoral and research training program, is a pan-European initiative supported by Horizon 2020, the EU Framework Program for Research and Innovation that promises more breakthroughs, discoveries and world-firsts by taking great ideas from the lab to the market.
With 10 participating European universities, 5 research institutes/public health bodies, 3 biomedical companies and 3 hospitals and 12 internationally renowned multidisciplinary scientists, of which 8 are members of the European Complement Network, the CORVOS program is a mutually beneficial partnership and a great example of the power of an industry and scientific collaboration.
At Svar we have long experience and a proven track-record within complement research and the development of complement system assay for commercial purposes.
We’re now bringing our skills and passion for the complement system to help in the fight against opportunistic infections. As an industry collaborator, we are happy to be able to contribute with our time and resources to build relationships with researchers and co-collaborators and see great gains in aligned with early stage researchers to discover new opportunities for research and commercialization.
Through the program, 15 early stage researchers will build their knowledge and experience to better understand the role of complement in opportunistic infections. Through our industry contribution they get a first-hand look at the process of developing commercially available assay, gaining valuable knowledge and experience in how they can translate research knowledge into clinical practice.
Our hope is that this collaborative program will produce groundbreaking research and innovation that can help solve complex problems related to the complement system.
